Two novel assays of alloantibody-secreting cells demonstrating resistance to desensitization with IVIG and rATG

American Journal of Transplantation

Volumn 8, Issue 1, 2008, Pages 133-143

  Perry, D K ^a   Pollinger, H S ^a   Burns, J M ^a   Rea, D ^a   Ramos, E ^a   Platt, J L ^b   Gloor, J M ^a   Stegall, M D ^a  

^a Mayo Clinic   (United States)

^b MAYO GRADUATE SCHOOL   (United States)

Author keywords

Alloantibody; HLA; Kidney transplant; Plasma cell; rATG

Indexed keywords

ALLOANTIBODY; HLA ANTIBODY; IMMUNOGLOBULIN; SYNDECAN 1; THYMOCYTE ANTIBODY;

ADULT; ALLOIMMUNITY; ANTIBODY PRODUCING CELL; ARTICLE; BONE MARROW CELL; CLINICAL ARTICLE; CONTROLLED STUDY; DESENSITIZATION; DRUG MEGADOSE; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; HUMAN; HUMAN CELL; IMMUNOMODULATION; KIDNEY TRANSPLANTATION; LOW DRUG DOSE; MALE; PLASMAPHERESIS; PRIORITY JOURNAL; SINGLE DRUG DOSE;

ADULT; AGED; ANTIBODY-PRODUCING CELLS; ANTILYMPHOCYTE SERUM; CELLS, CULTURED; DESENSITIZATION, IMMUNOLOGIC; FEMALE; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; ISOANTIBODIES; MALE; MIDDLE AGED;

EID: 37549061830     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2007.02039.x     Document Type: Article

References (38)

1. Available from http://www.unos.org accessed July 18, 2007.
2. Gebel HM, Bray RA. Sensitization and sensitivity: Defining the unsensitized patient. Transplantation 2000 69 : 1370 1374.
3. Slifka MK, Ahmed R. Long-lived plasma cells: A mechanism for maintaining persistent antibody production. Curr Opin Immunol 1998 10 : 252 258.
4. Bernasconi NL, Traggiai E, Lanzavecchia A. Maintenance of serological memory by polyclonal activation of human memory B cells. Science 2002 298 : 2199 2202.
5. Ellyard JI, Avery DT, Phan TG, Hare NJ, Hodgkin PD, Tangye SG. Antigen-selected, immunoglobulin-secreting cells persist in human spleen and bone marrow. Blood 2004 103 : 3805 3812.
6. Tyan D, Li V, Czer L, Trento A, Jordan S. Intravenous immunoglobulin suppression of HLA alloantibody in highly sensitized transplant candidates and transplantation with a histoincompatible organ. Transplantation 1994 57 : 553 558.
7. Montgomery RA, Zachary AA, Racusen LC, Leffell MS, King KE, Burdick J, Maley WR, Ratner LE. Plasmapheresis and intravenous immune globulin provides effective rescue therapy for refractory humoral rejection and allows kidneys to be successfully transplanted into cross-match-positive recipients. Transplantation 2000 70 : 887 895.
8. Schweitzer EJ, Wilson JS, Fernandez-Vina M, Fox M, Gutierrez M, Wiland A, Hunter J, Farney A, Philosophe B, Colonna J, Jarrell BE, Bartlett ST. A high panel-reactive antibody rescue protocol for cross-match-positive live donor kidney transplants. Transplantation 2000 70 : 1531 1536.
9. Jordan SC. Management of the highly HLA-sensitized patient. A novel role for intravenous gammaglobulin. Am J Transplant 2002 2 : 691 692.
10. Glotz D, Antoine C, Julia P, Suberbielle-Boissel C, Boudjeltia S, Fraoui R, Hacen C, Duboust A, Bariety J Desensitization and subsequent kidney transplantation of patients using intravenous immunoglobulin. Am J Transplant 2002 2 : 758 760.
11. Gloor JM, DeGoey SR, Pineda AA, Moore SB, Prieto M, Nyberg SL, Larson TS, Griffin MD, Textor SC, Velosa JA, Schwab TR, Fix LA, Stegall MD. Overcoming a Positive Crossmatch in Living Donor Kidney Transplantation. Am J Transplant 2003 3 : 1017 1023.
12. Jordan SC, Tyan D, Stablein D, McIntosh M, Rose S, Vo A, Toyoda M, Davis C, Shapiro R, Adey D, Milliner D, Graff R, Steiner R, Ciancia G, Sahney S, Light J. Evaluation of intravenous immunoglobulin as an agent to lower allosensitization and improve transplantation in highly sensitized adult patients with end-stage renal disease: Report of the NIH IG02 trial. J Am Soc Nephrol 2004 15 : 3256 3262.
13. Stegall MD, Gloor J, Winters JL, Moore SB, DeGoey S. A comparison of plasmapheresis vs high-dose IVIG desensitization in renal allograft recipients with high levels of donor specific alloantibody. Am J Transplant 2006 6 : 346 351.
14. Gloor JM, Cosio FG, Rea DJ, Wadei HM, Winters JL, Moore SB, DeGoey SR, Lager DJ, Grande JP, Stegall MD. Histologic findings in renal allografts one-year after positive crossmatch or ABO incompatible kidney transplantation. Am J Transplant 2006 6 : 1841 1847.
15. Haas M, Montgomery RA, Segev DL, Rahman MH, Racusen LC, Bagnasco SM, Simpkins CE, Warren DS, Lepley D, Zachary AA, Kraus ES. Subclinical acute antibody-mediated rejection in positive crossmatch renal allografts. Am J Transplant 2007 7 : 576 585.
16. Alwayn IPJ, Xu Y, Basker M, Wu C, Bunter L, Lambrigts D, Treter S, Harper D, Khamura H, Vitetta ES, Abrahams S, Awwad M, White-Scharf ME, Sachs DH, Thall A, Cooper DKC. Effects of specific anti-B/and or anti-plasma cell immunotherapy on antibody production in baboons: Depletion of CD20- and CD22-positive B cells does not result in significantly decreased production of anti-αGal antibody. Xenotransplantation 2001 8 : 157 171.
17. Ramos EJ, Pollinger HS, Stegall MD, Gloor JM, Dogan A, Grande JP. The effect of desensitization protocols on human splenic B cell populations in vivo. Am J Transplant 2007 7 : 402 407.
18. Zand MS, Vo T, Huggins J, Felgar R, Liesveld J, Pellegrin T, Bozorgzadeh A, Sanz I, Briggs BJ. Polyclonal rabbit antithymocyte globulin triggers B-cell and plasma cell apoptosis by multiple pathways. Transplantation 2005 79 : 1507 1511.
19. Zand MS. B-cell activity of polyclonal antithymocyte globulins. Transplantation 2006 82 : 1387 1395.
20. Pei P, Lee J-H, Shih N-J, Chen M, Terasaki PI. Single human leukocyte antigen flow cytometry beads for accurate identification of human leukocyte antibody specificities. Transplantation 2003 75 : 43 49.
21. Manz RA, Hauser AE, Hiepe F, Radbruch A. Maintenance of serum antibody levels. Annu Rev Immunol 2005 23 : 367 386.
22. O'Connell FP, Pinkus JL, Pinkus GS. CD138 (syndecan-1), a plasma cell marker. Am J Clin Pathol 2004 121 : 254 263.
23. Kazunga A, Sho H. CD27+: Memory B-cell marker. Imm Today 2001 2 : 204 206.
24. Bearden CM, Book BK, Sidner RA, Pescovitz MD. Removal of therapeutic anti-lymphocyte antibodies from human sera prior to anti-human leukocyte antibody testing. J Immunol Methods 2005 300 : 192 199.
25. Gloor JM, Moore SB, Schneider BA, Degoey SR, Stegall MD. The effect of rabbit antithymocyte globulin on anti-human leukocyte antigen antibody detection assays. Transplantation 2007 84 : 258 264.
26. Tarte K, De Vos J, Thykjaer T, Zhan F, Fiol G, Costes V, Reme T, Legouffe E, Rossi JF, Shaughnessy J Jr., Orntoft TF, Klein B. Gereration of polyclonal plasmablasts from peripheral blood B cells: A normal counterpart of malignant plasmablasts. Blood 2002 100 : 1113 1122.
27. Hofer T, Gwendolin M, Moser K, Yoshida T, Mei, Hebel K, Hauser A, Hoyer B, Luger EO, Dorner T, Manz RA, Hiepe F, Radbrunch A. Adaptation of humoral memory. Immunol Rev 2006 211 : 295 302.
28. Lakew, Mekuria, Nordström, Czerkinsky, Quiding-Järbrink. Combined immunomagnetic cell sorting and ELISPOT assay for the phenotypic characterization of specific antibody-forming cells. J Immunol Methods 1997 203 : 193 198.
29. Fan X, Ang A, Pollock-Barziv SM, Dipchand AI, Ruiz P, Wilson G, Platt JL, West LJ. Donor-specific B-cell tolerance after ABO-incompatible infant heart transplantation. Nat Med 2004 10 : 1227 1233.
30. Mulder A, Eijsink C, Kardol MJ, Franke-van Dijk ME, van der Burg SH, Kester M, Doxiadis II, Claas FH. Identification, isolation and culture of HLA-A2-specific B lymphocytes using MHC Class I tetramers. J Immunol 2003 171 : 6599 6603.
31. Zachary AA, Kopchaliiska D, Montgomery RA, Leffell MS. HLA-specific B cells: A methods for their detection, quantification, and isolation using HLA tetramers. Transplantation 2007 83 : 982 988.
32. Andersson UG, Bjork L, Skansen-Saphir U, Andersson JP. Down-regulation of cytokine production and interleukin-2 receptor expression by pooled human IgG. Immunology 1993 79 : 211 216.
33. Toyoda M, Pretrosyan A, Pao A, Jordan SC. Immunomodulatory effects of combination of pooled human gammaglobulin and rapamycin on cell proliferation and apoptosis in the mixed lymphocyte reaction. Transplantation 2004 78 : 1134 1138.
34. Ravetch JV, Nussenzweig M. Killing some to make way for others. Nat Immunol 2007 8 : 337 339.
35. Gloor JM, DeGoey S, Ploeger N, Gebel H, Bray R, Moore SB, Dean PG, Stegall MD. Persistence of low levels of alloantibody after desensitization in crossmatch positive living donor kidney transplantation. Transplantation 2004 78 : 221 227.
36. Zachary AA, Montgomery RA, Leffell MS. Factors associated with and predictive of persistence of donor-specific antibody after treatment with plasmapheresis and intravenous immunoglobulin. Hum Immunol 2005 66 : 364 370.
37. Martin L, Guignier F, Mousson C, Rageot D, Justrabo E, Rifle G. Detection of donor-specific anti-HLA antibodies with flow cytometry in eluates and sera from renal transplant recipients with chronic allograft nephropathy. Transplantation 2003 76 : 395 400.
38. Mohanankumar T, Waldrep JC, Phibbs M, Mendez-Picon G, Kaplan AM, Lee HM. Serological characterization of antibodies eluted from chronically rejected renal allografts. Transplantation 1981 32 : 61 66.